Tous Actualités
Suivre
Abonner november AG

november AG

euro adhoc: november AG
Restructuring & Recapitalisations
BAFin relieves BIOMED Beteiligungsgesellschaft and Dr. Claus Müller from submitting a mandatory offer

  Disclosure announcement transmitted by euro adhoc. The issuer is responsible
  for the content of this announcement.
16.11.2007
Erlangen, 16. November 2007. November AG has been notified that BAFIN
relieves BIOMED and Dr. Claus Müller from submitting a mandatory 
offer under section 37 of the german securities acquisitions and 
takeover act (wpüg) in conjunction with section 9 of the Offer 
regulations in case they gain control of the company. Submitting such
an offer would have been mandatory if a shareholder holds at least 
30% of a company's voting shares.
The decision made by bafin also makes it possible to implement the 
decisions made on 22th may 2007 at the annual general meeting (AGM)of
the company.
end of announcement                               euro adhoc 16.11.2007 14:24:07

Further inquiry note:

Marcus Weichert
Leitung PR/IR
Telefon: +49(0)9131 75088 868
E-Mail: weichert@november.de

Branche: Biotechnology
ISIN: DE0006762909
WKN: 676290
Index: CDAX, Technologie All Share, Prime All Share
Börsen: Börse Frankfurt / regulated dealing/prime standard
Börse Berlin / free trade
Börse Stuttgart / free trade
Börse Düsseldorf / free trade
Börse Hannover / free trade
Börse München / free trade

Plus de actualités: november AG
Plus de actualités: november AG